Showing results (601-610 of 631) with videos related to

Sort By:
Pageof 64
Circulation|September 1, 1988
Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activatorJ A Johns, H K Gold, R C Leinbach, et al.
Bio/Technology (Nature Publishing Company)|February 1, 1994
High yield production and purification of recombinant staphylokinase for thrombolytic therapyB Schlott, M Hartmann, K H Gührs, et al.
Blood|March 10, 2001
Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivoF Lluís, J Roma, M Suelves, et al.
The Journal of Cell Biology|May 19, 1997
Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/plasmin systemK T Sabapathy, M S Pepper, F Kiefer, et al.
Allergy|October 17, 2013
Vascular endothelial growth factor receptor 1 expression in nasal polyp tissueS Bobic, V Hox, I Callebaut, et al.
Lancet (London, England)|November 2, 1985
Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarctionM Verstraete, W Bleifeld, R W Brower, et al.
Circulation|September 1, 1989
Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activatorL W Gimple, H K Gold, R C Leinbach, et al.
The New England Journal of Medicine|March 8, 1984
Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarctionF Van de Werf, P A Ludbrook, S R Bergmann, et al.
Neurology|April 1, 1995
Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experienceM A Sloan, T R Price, C K Petito, et al.
The American Journal of Cardiology|August 1, 1987
Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rateM Verstraete, A E Arnold, R W Brower, et al.
Pageof 64